Condition

CML (2)

ALL (1)

AML (1)

Lymphoid Malignancies (1)

Myelodysplastic Syndromes (1)

Primary Myelofibrosis (1)

Overall Status

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Novartis Pharmaceuticals (1)

University of Alabama at Birmingham (1)

Collaborator

Intervention

infusion of cd34 selected hematopoietic stem cells (1)

nilotinib (1)

Study Documents

Prodigy technical sheet (1)

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

CML

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)

Not yet recruiting

AML
+5 more

Infusion of CD34 selected hematopoietic stem cells

Birmingham, Alabama

University of Alabama at Birmingham

Sep 14, 2023

CML Trial in United States (nilotinib)

Completed

CML

nilotinib

Birmingham, Alabama
+53 more

Feb 25, 2020